Correlation of T and B cell activities in vitro and serum IL-2 levels in systemic lupus erythematosus.
Open Access
- 1 August 1988
- journal article
- research article
- Published by Oxford University Press (OUP) in The Journal of Immunology
- Vol. 141 (3) , 827-833
- https://doi.org/10.4049/jimmunol.141.3.827
Abstract
There have been only a few studies indicating that B cell hyperactivity in SLE could depend on Th cell activation. In particular, circulating CD4+ cells were found to express Ia. Our own previous investigations have shown that the decreased IL-2 secretion capacity in vitro of CD4+ cells in SLE is restored to normal when the cells are rested for a few days in culture. This suggested the presence of activated, exhausted T cells in the circulation. In this study, we report several observations concerning T cell function in SLE. 1) Decreased IL-2 secretion in vitro of PBL was found to correlate significantly with increased spontaneous IgG secretion of such cells; immunosuppressive treatment of 22 patients with steroids plus cyclosporin A led, to a large extent, to a correction of both abnormalities. 2) 9 of 18 patients with active disease (and low IL-2 secretion in vitro) had increased IL-2 levels in serum by ELISA; two sera contained IL-2 biologic activity, and chromatography of one serum showed IL-2 in a high molecular size complex (Mr approximately 50,000) dissociable with 6 M urea. The serum levels of IL-2R were also frequently increased, even in less active SLE. 3) In cell culture experiments, the IgG secretion by purified B cells from 6 of 9 patients with active SLE was increased by autologous T cells acting either alone (3 patients) or synergistically with rIL-2 (3 patients); the B cells from all 9 patients showed increased IL-2 responsiveness compared with blood donor B cells. Taken together, these results provide new evidence that increased T cell activation occurs and plays a role in SLE.This publication has 31 references indexed in Scilit:
- Successful treatment of autoimmunity in NZB/NZW F1 mice with monoclonal antibody to L3T4.The Journal of Experimental Medicine, 1985
- Interleukin 2 deficiencies in rheumatoid arthritis and systemic lupus erythematosusClinical Immunology and Immunopathology, 1984
- B-CELL ACTIVITY IN SYSTEMIC LUPUS-ERYTHEMATOSUS - DEPRESSED INVIVO HUMORAL IMMUNE-RESPONSE TO A PRIMARY ANTIGEN (HEMOCYANIN) AND INCREASED INVITRO SPONTANEOUS IMMUNOGLOBULIN-SYNTHESIS1983
- Decreased production of and response to interleukin-2 by cultured lymphocytes from patients with systemic lupus erythematosus.Journal of Clinical Investigation, 1982
- T cell growth factor receptors. Quantitation, specificity, and biological relevanceThe Journal of Experimental Medicine, 1981
- Increased immunoglobulin-secreting cells in the blood of patients with active systemic lupus erythematosusThe American Journal of Medicine, 1980
- CIRCULATING AND POKEWEED MITOGEN-INDUCED IMMUNOGLOBULIN-SECRETING CELLS IN SYSTEMIC LUPUS-ERYTHEMATOSUS1979
- Immunoregulatory Aberrations in Systemic Lupus ErythematosusThe Journal of Immunology, 1978
- T Cell Growth Factor: Parameters of Production and a Quantitative Microassay for ActivityThe Journal of Immunology, 1978
- DETERMINATION OF ANTI-DNA ANTIBODIES BY A MODIFIED I-125-LABELED DNA-BINDING TEST - ELIMINATION OF NONSPECIFIC BINDING OF DNA TO NON-IMMUNOGLOBULIN BASIC-PROTEINS BY USING AN ANIONIC DETERGENT1976